UnitedHealth Group Incorporated (UNH)
Mexican Exchange · Mexico · prices in MXN · close of 22 Oct 2026
Key indicators
| Last close | MXN 7,945.83 |
|---|---|
| 52-week range | 4,639.25 – 7,983.63 |
| Return, 1 month / 3 months | +23.1% / +6.6% |
| Return, 1 year / 3 years | +22.6% / −13.0% |
| Trend | Uptrend |
| RSI (14) | 79 |
| Volatility (1 year) | 40.3% |
| Worst drawdown (1 year) | -30.5% |
| Average daily value traded | 10.14M MXN |
| Dividend yield | 2.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
UnitedHealth Group is a healthcare company based in the United States. Its insurance arm offers medical plans to individuals, employers and government health programmes, while its health services arm provides pharmacy benefits, data and analytics, and care delivery through clinics and physician groups. The company serves customers across the American healthcare system, combining insurance coverage with services that support how care is paid for and provided.
On this site UnitedHealth Group Incorporated appears as a stock on the Mexican Exchange (Mexico), code UNH, with prices in Mexican pesos (MXN). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
UnitedHealth Group Incorporated (UNH) trades on the Mexican Exchange in Mexico. It last closed at MXN 7,945.83 on 22 October 2026.
Its price-based Market X-Ray is 63 out of 100 (a fair price profile), ranking 76 of 361 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 22.6% and over the last three months it rose 6.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Mexican Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 87 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 26.9% | ||
| From 52-week high | 0.0% | ||
| Momentum | 64 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 6.6% | ||
| 6-month return | 31.0% | ||
| 12-month return, skipping the last month | -0.4% | ||
| Stability (higher is calmer) | 29 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 40.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -30.5% | ||
| Liquidity | 80 · Strong | Trades actively. | |
| Average daily value traded | 10.14M MXN | ||
| Zero-volume days | 3.3% | ||
| Income | 61 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 2.0% | ||
| Years with dividends | 6 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | +5.9% |
|---|---|
| 1 month | +23.1% |
| 3 months | +6.6% |
| 6 months | +31.0% |
| 1 year | +22.6% |
| 3 years | −13.0% |
| 5 years | −3.5% |
Signals
| 50-day / 200-day average | 6,793.50 / 6,261.86 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | Yes |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 157.89 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 14 Sep 2026 | MXN 39.7716 |
| 15 Jun 2026 | MXN 39.9073 |
| 9 Mar 2026 | MXN 39.2640 |
| 8 Dec 2025 | MXN 40.2938 |
| 15 Sep 2025 | MXN 40.5988 |
| 16 Jun 2025 | MXN 41.7237 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Mexican Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.